About Chemours
Chemours is a company based in Wilmington (United States) founded in 2015. The company has 6,000 employees as of December 31, 2024. Chemours has completed 2 acquisitions, including ICOR International and Southern Ionics.
- Headquarter Wilmington, United States
- Employees 6000 as on 31 Dec, 2024
- Stage Public
-
Sectors
Chemicals & Materials
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Chemours Company (The)
-
Annual Revenue
$5.78 B (USD)-4.87as on Dec 31, 2024
-
Net Profit
$86 M (USD)136.13as on Dec 31, 2024
-
EBITDA
$759 M (USD)-6.53as on Dec 31, 2024
-
Latest Funding Round
$358.71 K (USD), Grant
Apr 01, 2020
- Investors
-
Employee Count
6000
as on Dec 31, 2024
-
Investments & Acquisitions
ICOR International
& 1 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Chemours
Chemours is a publicly listed company on the NYSE with ticker symbol CC in USA, operating in the Process industries sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
People of Chemours
Unlock access to complete
Unlock access to complete
Software Development Team
107 people
Sales and Marketing
23 people
Product Management Team
13 people
Legal and Compliance
10 people
Human Resources and Administration
10 people
Leadership Team
9 people
Finance and Accounting
8 people
Data Analysis and Operations Team
4 people
Unlock access to complete
Funding Insights of Chemours
Investors in Chemours
Chemours has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include European Union.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
|
Locked | Locked | Locked |
Investor details for Chemours
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Chemours
Chemours has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include ICOR International and Southern Ionics.
Investment portfolio details for Chemours
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
International news and analysis are delivered globally with expert insights.
|
Locked | Locked | 1998 | Locked | |
|
Zircon, ilmenite, and rutile mining services are provided worldwide.
|
Locked | Locked | 1980 | Locked |
Complete acquisition details for Chemours
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Chemours
Detailed financials for Chemours
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Chemours Comparisons
Peer comparison for Chemours
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Chemours
Detailed competitors of Chemours
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Chemours
Complete news archive for Chemours
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Chemours
Chemours was founded in 2015 and raised its 1st funding round 1 year after it was founded.
Chemours is headquartered in Wilmington, United States. It is registered at Wilmington, Delaware, United States.
Mark Vergnano is the current CEO of Chemours.
As of Dec 31, 2024, the latest employee count at Chemours is 6,000.
Annual revenue of Chemours is $5.78B as on Dec 31, 2024.
Chemours was founded in 2015 as a chemical corporation based in Wilmington, United States. Operations focus on titanium technologies, fluoro products, and chemical solutions supplied to industries including automotive, paints, plastics, electronics, energy, and telecommunications. Customers in over 130 countries are served worldwide. Annual revenues of 6.63 billion and net profit of 0.99 billion were recorded in 2018.
Yes, Chemours is publicly traded on NYSE under the ticker symbol CC.
Chemours has made 2 acquisitions, including ICOR International, and Southern Ionics.
Chemours has 1 investor. Key investors include European Union.
The ticker symbol of Chemours is CC on NYSE.